Skip to content

The impact of endogenous testosterone for gender differences in pain, sensory perception and therapy of pain

The impact of endogenous testosterone for gender differences in pain, sensory perception and therapy of pain - TestoSense

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00010854
Enrollment
120
Registered
2017-01-03
Start date
2014-12-09
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Testosterone and sensory perception

Interventions

Group 1: Participants with assumed lack of endogenous testosterone: Testing the sensory function by standardized test battery of sensory funtion (QST) and determine endogenous inhibition dependent on

Sponsors

Klinik für Anästhesiologie, operative Intensivmedizin und Schmerztherapie
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: male sex, legal age, assumed lack of endogenous testosterone (in patient group)

Exclusion criteria

Exclusion criteria: Chronic pain condition, chronic nervous diseases, chronic psychiatric diseases, chronic analgetic use, abuse, other conditions with alterations in pain

Design outcomes

Primary

MeasureTime frame
endogenous inhibition: Conditioned-Pain-Modulation-Effect (CPM-Effect),

Secondary

MeasureTime frame
Variables from QST (quantitative sensory testing) protocol (Cold Detection Threshold, CDT; Warmth Detection Threshold, WDT; Thermal Sensory Limen, TSL; Paradoxal Heat Sensation, PHS; Cold Pain Threshold,CPT; Heat Pain Threshold, HPT; Mechanical Detection Threshold, MDT; Mechanical Pain Threshold, MPT; mechanical pain sensitivity, MPS; Dynamic Mechanical Allodynia, DMA Wind-Up-Ration, WUR; Vibration Detection Threshold, VDT; Pressure Pain Threshold, PPT)

Countries

Germany

Contacts

Public ContactVasco Deichert

Klinik für Anästhesiologie, operative Intensivmedizin und Schmerztherapie

vasco.deichert@ukmuenster.de0049-251-83-48317

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026